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Kindlin-2 is a multidomain intracellular protein that can be recruited to 𝛽-integrin domains to activate signaling, initiate
transcriptional programs, and bind to E-cadherin. To explore its involvement in cell fate decisions inmesenchymal cells, we studied
the effects of Kindlin-2 modification (overexpression/knockdown) in induced pluripotent cell-derived mesenchymal stromal
cells (iPSC-MSCs). Kindlin-2 overexpression resulted in increased proliferation and reduced apoptosis of iPSC-MSCs, as well
as inhibition of their differentiation towards osteocytes, adipocytes, and chondrocytes. In contrast, siRNA-mediated Kindlin-
2 knockdown induced increased apoptosis and increased differentiation response in iPSC-MSCs. The ability of iPSC-MSCs to
adhere to VCAM-1/SDF-1𝛼 under shear stress and to migrate in a wound scratch assay was significantly increased after Kindlin-2
overexpression. In contrast, inhibition ofmixed lymphocyte reaction (MLR) was generally independent of Kindlin-2modulation in
iPSC-MSCs, except for decreased production of interleukin-2 (IL-2) after Kindlin-2 overexpression in iPS-MSCs. Thus, Kindlin-2
upregulates survival, proliferation, stemness, and migration potential in iPSC-MSCs and may therefore be beneficial in optimizing
performance of iPSC-MSC in therapies.
1. Introduction
Kindlins are intracellular multidomain proteins with binding
motifs that mediate their interaction with integrins, the
cytoskeleton, or, in the case of Kindlin-2, E-cadherin [1].
Kindlins can activate integrins by adhering to their 𝛽 cyto-
plasmic chain using the FERM domain to engage a-actinin,
migfilin, or integrin-linked kinase (ILK), which leads to actin
remodeling, cell migration, and lamellipodia formation [2].
Kindlin-2 was found to play a role during embryogenesis by
altering the proliferation potential and migration behaviour
of different cell types, and the deregulation of Kindlin-2 can
halt embryonic development and induce embryonic lethality
[3]. Kindlin-2 was found to trigger epithelial mesenchymal
transition (EMT) by activating Wnt signaling in vitro [4],
resulting in increased adhesion, migration, and proliferation
[5]. Kindlin-2 may also inhibit the growth and migration
of colorectal cancer cells [6]. Because EMT occurs dur-
ing induced pluripotent stem cells (iPSCs) differentiation
towards mesenchymal-like cells [7], we aimed to investigate
the role of Kindlin-2 in the functions of iPSC-derived MSC.
We hypothesized that Kindlin-2 may increase proliferation,
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enhance migration and adhesion, and increase functional
activation of iPSC-MSCs and thus might provide a basis
for engineering iPSC-MSCs in a therapeutically desirable
manner.
Obtaining sufficient amounts ofMSCs has been a limiting
factor for their use in transplantation. Furthermore, the
robust functional activation of MSCs, such as migration
towards injured tissues, adhesion for homing in areas in need
of tissue repair, and resistance to apoptosis after transfusion,
was thought to be crucial for therapeutic efficiency in recip-
ients [8, 9]. So far, it is not clear to what extent alterations in
the proliferation, migration, and adhesion of therapeutically
applied MSCs might influence the capability of the cells
to mediate tissue repair or immune regulation. Altogether,
“superfunctional” MSCs should display high expandability
and survival and boosted adhesion and migration with
preserved immunoregulatory properties that are likely to pro-
mote the therapeutic potential of MSCs in cellular therapies.
In a previous study, we characterized the differentiation
of iPSCs towards MSCs to obtain a functional substitute
for ex vivo MSCs [7, 10]. We have shown that iPSCs can
be differentiated into MSCs, including development from
“epithelial-like” iPSCs towards spindle-shaped MSCs that
are capable of proliferation in an undifferentiated stage
and of induction into multilineage differentiation. More-
over, iPSC-MSCs showed similar hematopoietic support and
immunomodulatory effects to BM-MSCs [10]. In this study,
we aimed to modify Kindlin-2 expression in iPSC-MSCs to
modulate their proliferative and functional properties. We
demonstrate that Kindlin-2 expression levels modulate the
adhesion and migration properties of iPSC-MSCs as well as
their proliferation, apoptosis, differentiation, and immune-
suppression properties.
2. Materials and Methods
2.1. iPS Cell Culture and Mesenchymal Differentiation.
Human iPSCs were provided from in-house supplies as
described [11]. Briefly, human fetal liver fibroblasts (FLF)
were transduced via lentiviral expression of reprogram-
ming factors Oct4, Sox2, Klf4, and c-Myc (OSKM) and
cultured on irradiated mouse embryonic fibroblasts (MEF)
in medium containing DMEM/F-12, 20% knockout serum
replacement (Thermo Fisher,Waltham,MA,USA), 20 ng/mL
human recombinant basic fibroblast growth factor (bFGF,
provided from Leibniz University Hannover), 0.1mM 𝛽-
mercaptoethanol (Thermo Fisher), 1mM L-glutamine, 1%
nonessential amino acids, and 1% penicillin/streptomycin (all
from Sigma-Aldrich). Cells were split weekly using collage-
nase IV (Thermo Fisher), and cells were plated on Matrigel-
coated (Corning) plates. Differentiation/enrichment of iPSCs
to MSCs was conducted as described [10]. In brief, human
iPSC colonies grown on Matrigel were maintained with
MSC induction media consisting of DMEM (low-glucose,
Sigma-Aldrich, Darmstadt, Germany), 10% defined fetal
bovine serum (FBS, Stem Cell Technologies, Vancouver,
BC, Canada), 1% nonessential amino acids, 1% penicillin-
streptomycin, and 2 ng/mL human recombinant bFGF for 7
days. Next, cells were treated with collagenase IV for 3min
at 37∘C, dissociated by glass beads and gentle pipetting, and
then passed through 40mm cell strainers (Fisher Scientific,
Schwerte, Germany). Single cells were seeded onto gelatin-
coated plates at 1 × 104 cells/cm2 in MSC media.
2.2. Transfection and Establishment of a Stable Cell Line. The
iPSC-MSCs were transfected with four different constructs,
including Flag-Kindlin-2 or Flag vector, control short hair-
pin RNA (shRNA), or Kindlin-2 shRNA. The vectors were
received as a gift from Hongquan Zhang, Peking University
Health Science Center, Beijing, China. Plasmid structures
were described by An et al. [12]. The cells were plated in
6-well plates at a density of 1 × 104 cells/cm2 24 h before
transfection. The plasmids were expanded in Escherichia coli
(E. coli strain DH5a) for 16 h and purified by QIAfilter Maxi
Kit (Qiagen, Hilden, Germany) following the manufacturer’s
protocol. The purified plasmid DNA (3mg/mL) was resus-
pended in 97.5 𝜇L of low-glucose DMEM, and then 2.5 𝜇L of
0.1mM polyethylenimine (PEI) was added (Sigma-Aldrich).
The PEI/plasmid DNA solution was vortexed immediately
to make the PEI/plasmid complexes. The complexes were
allowed to interact for 15min before they were used at room
temperature. Then, 600𝜇L of low-glucose DMEM with 10%
FBS was added to the complexes to make a transfection
mixture; finally, the mixture was added to the cells. After 3
hours, the medium was removed and replaced with normal
MSCs media for 2 days. After two days, cells were cultured
under 500𝜇g/mL G418 (Sigma-Aldrich) selection until all
nontransfected cells disappeared.
2.3. Proliferation Assays. Cell proliferation assays were per-
formed with WST-1 and BrdU colorimetric assays (both
from Roche) according to the manufacturer’s protocols. For
the WST-1 assay, cells were plated in 96-well plates at an
initial density of 2000 cells/well. The growth graphs were
made five days after transfection by measuring Formazan
dye in the conditioned media. For the quantitative colori-
metric BrdU proliferation assay (Roche), BrdU was added
12 hours before fixation. Then, anti-BrdU-POD was added,
and the reaction was detected by adding the subsequent
substrate. Colorimetric assays were detected with a scanning
multiwell spectrophotometer (Bio-Rad). BrdU-incorporated
cells were counted five days after transfection. Cells were
fixed with 4% paraformaldehyde (PFA) and then subjected to
immunofluorescence staining for 5-bromo-2󸀠-deoxyuridine
(BrdU) (Abcam). The cells were counted under a fluorescent
microscope, and the ratio of BrdU positive nuclei to the total
number of nuclei stained with DAPI (Sigma-Aldrich) was
determined.
2.4. Flow Cytometry. To assess the expression of CXCR-4
after modulation of Kindlin-2 expression, flow cytometric
analysis was performed 3 days after transfection as follows:
single cell suspensions were prepared by trypsin digestion
(Life Technologies) and washed with cold PBS containing
1% bovine serum albumin BSA (Merck Millipore). Next, 2
× 105 cells were incubated for 30 minutes with the respective
APC-conjugated monoclonal antibody of CXCR-4 (all from
BD Biosciences) and the suspensions were resuspended at a
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density of 2 × 105 cells per 200𝜇L in cold PBS containing 1%
BSA.Nonspecific fluorescence was determined by incubation
of cell aliquots with isotype-matched monoclonal antibody.
Samples were run on a FACSCalibur (BD Biosciences, CA,
USA) cytometer using FACSDiva software. For each analysis,
a minimum of 10,000 cells were assayed. Data were further
processed using FlowJo software (Tree Star, Ashland, Oregon,
USA).
2.5. Flow Chamber Adhesion Assay. For adhesion assays, 105
iPSC-MSCs were allowed to rest for 3min on a laminar
flow chamber slide (𝜇-slide, ibiTreat; IBIDI Systems, Munich,
Germany) mounted on an inverted microscope as previously
described [13]. Briefly, flow chambers were precoated with
2 𝜇g/mL VCAM-1 fusion protein and cocoated with SDF-1,
both fromR&DSystems (1 𝜇g/mL). Subsequently,HBSS/0.1%
BSA (prewarmed to 37∘C) was flushed through the chambers
at the indicated calculated shear stresses with increases in
steps between 0.35 and 15 dyn/cm2 every 30 s. Images were
taken, and the adherent cells were counted in four fields for
every condition.
2.6. Migration Assay. Cells were seeded at a density of 3 ×
104 cells on each side of an Ibidi culture insert for live cell
analysis (Ibidi, Munich, Germany) with 500𝜇M separation
between each side of the well and were allowed to grow
for 24 h. Cells were pretreated with 30 𝜇M mitomycin C for
30min before removal of the insert, and cells in the insert
were incubated in DMEMwith or without 30 𝜇Mmitomycin
C. The cells were photographed using the 10x objective
(Zeiss) after insert removal (0 h) and following 24 and 36 h
of incubation. Transmigration assays were performed in
transwells (Corning, New York, USA) 6.5mm in diameter
with 8 𝜇m pore filters. The upper side of the transwell filter
was coated for 1 hour at 37∘Cwith 0.1% bovine gelatin (Sigma-
Aldrich) in phosphate-buffered saline (PBS). Then, 5 × 105
transfected iPSC-MSCs suspended in 200𝜇L of migration
medium containing RPMIwith 0.25% bovine serum albumin
(Sigma-Aldrich) were added to the upper chambers, and
600𝜇L of migration medium supplemented with 10% FBS
was added to the bottom chamber. After 24 h and 48 h
incubation of the transwells at 37∘C/5% CO2, the upper side
of the filters was carefully washed with cold PBS, and cells
remaining on the upper face of the filters were removed
with a cotton wool swab. Transwell filters were stained using
a Giemsa solution (Sigma-Aldrich), cut out with a scalpel,
and mounted onto glass slides with the lower face turned
upwards. The total number of cells that had migrated was
counted using light microscopy at 200x magnification. Each
experiment was performed in triplicate.
2.7. Real-Time PCR. Total cellular RNA was isolated using
TRIzol reagent (Life Technologies). Resultant RNA was
subjected to DNase treatment and cDNA Synthesis Kit
(Life Technologies) with random hexamers. Power SYBR
Green Master Mix qRT PCR assays were performed with
the StepOne Plus Cycler (Applied Biosystems) using the
standard settings. Samples were collected from at least three
independent experiments. Kindlin-2 primers used in the real-
time PCR were forward sequence 5󸀠-TGTCTCCCCGCT-
ATCTAAAAAAGT-3 and reverse sequence 5󸀠-TGATGG-
GCCTCCAAGATTCT-3. GAPDH was used as an internal
control with the forward sequence 5󸀠-CTGAGAACGGGA-
AGCTTGT-3 and reverse sequence 5󸀠-GGGTGCTAAGCA-
GTTGGT-3. Expression of genes was determined using the
comparative CT method (2−ΔΔCT).
2.8. Immune-Suppression Assays. Twenty-four hours after
transfection of iPSC-MSCs, mixed lymphocyte reaction
(MLR) cultures were inoculated with 5 × 104 mitomycin C-
treated (Sigma-Aldrich) human peripheral blood mononu-
clear cells (PBMCs) as stimulators and 2 × 105 human CD8+
T-cells isolated from normal blood donors after informed
consent in 96-well round-bottom plates in 200𝜇L of com-
plete medium containing RPMI 1640 (Life Technologies)
supplemented with 0.1mM 𝛽-mercaptoethanol, 10% FBS,
GlutaMAX I (Life Technologies), 100U/mL penicillin, and
100 𝜇g/mL streptomycin in the presence or absence of iPSC-
MSCs and BM-MSCs as previously described [10]. Cultures
were incubated for 5 days in 37∘C/5% CO2. BrdU was added
to the mixed lymphocyte reaction 12 hours before fixation.
Then, anti-BrdU-POD was added, and the reaction was
detected by adding the subsequent substrate. Colorimetric
assays were detected with a scanning multiwell spectropho-
tometer (Bio-Rad). IL-2 and IFN-𝛾 concentrations were
determined inMSC/MLR coculture supernatants using com-
mercially available ELISA (BD Biosciences) according to the
manufacturer’s instructions. Briefly, 50 𝜇L of ELISA diluent
was added to the IL-2 or IFN-𝛾 coated 96-well plates. Then,
100 𝜇L of sample supernatant or standard controls was added
to the wells for 2 hours at room temperature. After washing
the samples five times, 100 𝜇L of the prepared working detec-
tor was incubated in each well for 1 hour in RT. After washing
the samples seven times, 100 𝜇L of TMB substrate was added
and incubated for 30minutes in RT, followed by adding 50 𝜇L
of stop solution. Colorimetric assays were detected at 450 nm
using a multiwell spectrophotometer (Bio-Rad).
2.9. Annexin V Assay. Viability of iPSC-MSCs after trans-
fection was monitored by FACS analysis using annexin
V-propidium iodide staining. Cultured iPSC-MSCs were
detached, centrifuged, suspended in PBS, and stained with
annexin V-FITC and propidium iodide (BD Pharmingen,
San Diego, CA, USA). Apoptotic cells were identified as an
annexin V-positive/propidium iodide-negative population
using the FACSCalibur cytometer (BD) and FlowJo software
(Tree Star).
2.10. Differentiation of iPSC-MSCs after Kindlin-2 Modifica-
tion. Differentiation induction of iPSC-MSCs was carried
out for 21 days in different differentiation media, 24 hours
after transfection. In total, 104 cells were seeded per well in
six-well plates (TPP). To induce osteogenic differentiation,
cells were cultured with MSC medium containing 1 𝜇M
dexamethasone, 0.5 𝜇M ascorbic acid, and 10mM b-glycerol
phosphate (all from Sigma-Aldrich). For adipogenic induc-
tion, cells were cultured in MSCmedium supplemented with
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50𝜇g/mL indomethacin (Sigma-Aldrich), 50𝜇g/mL ascorbic
acid, and 100 nM dexamethasone. For chondrogenic differ-
entiation, iPSC-MSCs were centrifuged in 0.2mL of medium
at 500 g for 10min in 15mL Falcon tubes to form a pellet.
The pellets were cultured in MSC medium supplemented
with 0.01𝜇M dexamethasone, 397 𝜇g/mL ascorbic acid-2-
phosphate (Sigma-Aldrich), 1mM sodium pyruvate (Sigma-
Aldrich), 10 ng/mL transforming growth factor-𝛽1 (TGF-𝛽1,
Life Technologies), and 1% insulin-transferrin-selenium (Life
Technologies). Osteogenesis was assessed by Alizarin Red
staining, adipogenesis was assessed by Oil Red-O staining,
and chondrogenesis was assessed by Alcian Blue staining (all
from Sigma-Aldrich).
2.11. Statistical Analysis. The results were expressed as the
mean ± standard error of the mean (SEM). Analyses of
iPSC-MSCs in vitro were performed using one-way repeated
measures analysis of variance (ANOVA) followed by Tukey’s
post hoc test multiple group comparison to analyze the group
differences of the in vivo data. The mean difference was sig-
nificant at the 𝑝 < 0.05 level. For quantification with ImageJ
software, a total of 30 fields of each group were assayed.
3. Results
3.1. Kindlin-2 Expression Pattern and Targets in iPSC-MSCs.
As a first approach to assess the role of Kindlin-2 in MSCs,
we analyzed its mRNA levels of Kindlin-2 in iPS, BM-MSC,
and iPS-MSCs. We found that BM-MSCs express higher
levels of Kindlin-2 RNA compared with iPSCs (𝑝 ≤ 0.05,
Figure 1(a)). Different passages of iPSC-MSCs showed a slight
increase in mRNA and protein expression levels of Kindlin-
2 compared to iPS cells, but still lower than BM-MSCs
(Figure 1(b)). For overexpression/knockdown experiments,
we used iPSC-MSCs passages 4–6. Quantitative RT-PCR
results demonstrated the successful transfection of iPSC-
MSCs with Kindlin-2 constructs compared to control plas-
mids (Figure 1(c)).The corresponding expression of Kindlin-
2 protein is shown in Figures 1(d) and 1(e).
3.2. Kindlin-2 Promotes Proliferation/Survival and Suppresses
Apoptosis of iPSC-MSCs. Previously, we showed that iPSC-
MSCs displayed a shorter doubling time than BM-MSCs
and reached senescence at later passages than BM-MSCs
[10]. To investigate the effects of Kindlin-2 on proliferation
and survival in iPS-MSCs, we performed a BrdU incorpo-
ration assay (Figure 2(a)) that showed a significant increase
after Kindlin-2 Flag transfection compared to the vector
control. In contrast, a small but insignificant decrease in
BrdU incorporation was observed after Kindlin-2 shRNA
transfection.The same pattern was observed in aWST-1 assay
(Figure 2(b)).We confirmed these data by counting theBrdU-
incorporated iPSC-MSCs after transfection. The number
of BrdU+ cells was also significantly higher in Kindlin-2
Flag transfected cells, and there was a minor decrease after
Kindlin-2 shRNA transfection compared to control vectors
(Figures 2(c) and 2(d)). We next looked for apoptosis via
annexin V expression after transfection (Figures 3(a) and
3(b)). The percentage of apoptotic cells was significantly
decreased to 3–6% in Kindlin-2 Flag transfected cells when
compared to the corresponding control group (7–12%).More-
over, Kindlin-2 knockdown significantly increased the apop-
totic cell population in Kindlin-2 shRNA transfected cells to
17–21% (Figures 3(a) and 3(b)). In parallel, expression of the
MSC undifferentiated cell markers, CD73 and CD105, was
increased in Kindlin-2 overexpressing cells and decreased
after Kindlin-2 knockdown (Figures 3(c) and 3(d)).
3.3. Differentiation Potential after Kindlin-2 Overexpression
in iPSC-MSCs. To investigate whether the cells may have
various differentiation capabilities after transfection, we per-
formed gene expression analysis and morphological analysis
on iPSC-MSCs cultured for 21 days under various conditions.
During osteogenic differentiation, we detected less calcium
accumulation in Kindlin-2 Flag transfected iPSC-MSCs with
significantly lower expression of osteocalcin and alkaline
phosphatase, whereas expression of alkaline phosphatase
was significantly (𝑝 ≤ 0.05) higher in Kindlin-2 shRNA
transfected cells compared to control vector (Figure 4(a)).
In chondrogenic differentiation, Kindlin-2 Flag transfected
cells produced a small and undifferentiated cartilage pellet;
however, the other groups created a larger and fully differenti-
ated cell pellet observed in histological analysis (Figure 4(b)).
Furthermore, Kindlin-2 overexpression significantly (𝑝 ≤
0.05) decreased aggrecanmRNA levels while cells transfected
with Kindlin-2 shRNA had significantly (𝑝 ≤ 0.05) higher
expression of aggrecan and collagen type II (Figure 4(b)).
We observed increased numbers of lipid droplets in Kindlin-
2 shRNA transfected iPSC-MSCs and a significantly higher
expression (𝑝 ≤ 0.05) of PPAR-𝛾 and LPL, while the number
of lipid droplets was decreased in iPSC-MSCs transfected
withKindlin-2 Flag vectorwith significantly lower expression
(𝑝 ≤ 0.05) of PPAR-𝛾 and LPL (Figure 4(c)).
3.4. Adhesion of iPSC-MSCs under Shear Stress. To investigate
how iPSC-MSCs interact with a relevant homing receptor
that activates integrins under shear flow, a parallel plate
flow chamber system was used with VCAM-1 + SDF-1𝛼
coating.We assessed adhesion of iPSC-MSCs anddetermined
the percentage of their capability to remain adherent in
different shear stresses from low (0.35 dynes/cm2) to high
(15 dynes/cm2) levels. Determination of numbers of adher-
ent cells at each shear stress indicated that Kindlin-2 Flag
transfected cells had a higher affinity to adhere to VCAM-
1 + SDF-1𝛼 coated surface than control vector transfected
cells. As shown in Figure 5, after increasing the shear stress
to 2 dynes/cm2, 59 ± 5% of the Kindlin-2 Flag transfected
cells remained attached to the surface compared to 42 ±
6% of the control vector and 36 ± 6% of Kindlin-2 shRNA
transfected cells. A more prominent difference was observed
after increasing the shear stress to 5 dynes/cm2 in which on
average 51 ± 4% of Kindlin-2 Flag transfected cells remained
attached, whereas control cells declined to 25 ± 5%, and the
cells in the Kindlin-2 shRNA group declined to 19 ± 4%.
In parallel, 25.5 ± 4.2% of Kindlin-2 Flag cells were also
found positive for CXCR4 by flow cytometry, compared to
0.052±0.05% in control vector, 0.02±0.01% in control shRNA,
and 0 ± 0% in Kindlin-2 shRNA iPS-MSCs, respectively
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Figure 1: Kindlin-2 expression pattern, overexpression/knockdown, and targets. (a) mRNA expression levels of Kindlin-2 in F134 iPSCs
and different passages of iPSC-MSCs indicated significant differences with BM-MSCs; total proteins were extracted from all cell types. (b)
Western blotting was performed using an anti-Kindlin-2 monoclonal antibody. (c) Real-time qPCR was performed to quantify mRNA levels
of Kindlin-2 in iPSC-MSCs (passages 1–3) with Kindlin-2 overexpression or knockdown. (d, e)Western blot analysis (d) and densitometry (e)
performed with ImageJ software were performed and indicate efficient overexpression and knockdown. Data represents the mean expression
values normalized to the housekeeping gene GAPDH. ∗Significance difference 𝑝 ≤ 0.05. ∗∗Significance difference 𝑝 ≤ 0.01.
(means + SD; 𝑛 = 3; not shown in figure). Thus, Kindlin-2
overexpression significantly (𝑝 ≤ 0.05) increased the adhe-
sion to VCAM-1 + SDF1𝛼 coated flow chamber slides at shear
stresses between 2 and 15 dynes/cm2, along with an increased
expression of CXCR4.
3.5. Migration Potential of iPSC-MSCs after Kindlin-2 Over-
expression. We next investigated the migration potential of
iPSC-MSCs after transfection with the Kindlin-2 constructs
using transwell culture inserts. We found a significant differ-
ence in the number of transmigrated cells both at 24 h and
at 36 h between Kindlin-2 Flag transfected cells (52 ± 13%
versus 20 ± 11% after 24 h and 86 ± 11% versus 37 ± 7%
after 36 h). However, these differences were not significant
between Kindlin-2 shRNA and control groups (Figure 6(a)).
We observed that, at 24 h after transfection, 429 ± 31 cells
migrated to the lower surface of the culture insert in Kindlin-
2 Flag transfected iPSC-MSCs, but only 285 ± 66 cells were
counted in the control group (𝑝 ≤ 0.05). Moreover, the num-
bers of cells that migrated decreased to 212 ± 37 in Kindlin-2
shRNA transfected cells, which was significantly lower (𝑝 ≤
0.05) than the control group. Kindlin-2 Flag transfected cells
also migrated significantly better (𝑝 ≤ 0.05) than cells in
the control group after 48 h of incubation (969 ± 140 cells for
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Figure 2: Kindlin-2 regulates iPSC-MSCs cell growth. Cell growth was measured with BrdU (a) andWST-1 (b) ELISA assays and indicated a
significantly higher proliferation potential of Kindlin-2 overexpressing cells. BrdU+ cells were counted 5 days after transfection and showed
a significantly higher percentage of BrdU+ cells in Kindlin-2 overexpressing cells compared to control Flag (c and d). DAPI was used as a
counterstain. ∗Significance difference between the indicated groups 𝑝 ≤ 0.05.
Kindlin-2 Flag versus 633 ± 157 cells for control). Although
we observed a reduced number of migrating cells in the
Kindlin-2 shRNA group compared to the control group, this
difference was not statistically significant (Figure 6(b)). In
conclusion, Kindlin-2 levels resulted in modulated migration
of iPS-MSCs.
3.6. Kindlin-2 and Anti-Inflammatory Effects of iPSC-MSCs.
Previously, we have shown that iPSC-MSCs exhibit potent
immunomodulatory function in a mixed lymphocyte culture
(MLR) assay by decreasing CD4+ T-lymphocyte proliferation
and decreasing IFN-𝛾 secretion. In this study, we used
Kindlin-2 Flag/shRNA transfected iPSC-MSCs and BM-
MSCs to determine whether Kindlin-2 expression levels may
differentially affect the immunomodulatory properties of
these cells in an MLR assay. Overall, our results indicate that
there was no significant difference in Kindlin-2 Flag/shRNA
expressing iPS-MSCs compared to corresponding controls.
However, all groups of iPSC-MSCs aswell as BM-MSCs could
significantly reduce numbers of CD4+ T-cells or release of
IFN-𝛾 compared to MLR without the feeder layer (Figures
7(a) and 7(b)). However, there were no significant differences
in released IFN-𝛾 in all MLR assays between iPSC-MSCs or
BM-MSCs used as feeder cells (Figure 7(b)). Only Kindlin-
2 expressing iPSC-MSCs or BM-MSCs were able to signifi-
cantly decrease in IL-2 secretion, while the other 3 groups did
not show statistically significant differences with the control
group (Figure 7(c)).
4. Discussion
4.1. Kindlin-2 Expression during Derivation of iPSC-MSCs.
This study shows that Kindlin-2 is an integrin-associated
protein that can alter the phenotype of iPSC-MSCs in terms
of proliferation as well as adhesive and migratory properties
towards a more primitive phenotype and in a way that is
desirable for MSCs to be used as cellular therapeutics [14, 15].
It has been previously reported that Kindlin-2 can regulate
cell-cell and cell-ECM adhesion as well as cell migration via
integrin and integrin-linked kinase (ILK) activation [16–18].
Kindlin-2 has been shown to play a crucial role inmodulation
of integrin signaling and activation, which assists the cell in
sensing and interacting with the surrounding environment
[19]. Kindlin-2 not only modulates inside-out signaling by
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Figure 3: Kindlin-2 regulates apoptosis and stem cell markers in iPSC-MSCs.The iPSC-MSCs were stained using annexin V and propidium
iodide for analyzing cell apoptosis after transfection with Kindlin-2 constructs and quantified for early and late apoptotic cells. Kindlin-2
knockdown significantly increased apoptotic cells while Kindlin-2 overexpression significantly decreased apoptotic cells compared to control
Flag (a). Data were presented as the mean ± SEM from three independent experiments. Dot plots showing single experiments for annexin
V/propidium iodide double positive cells for late apoptotic cells (b). (c) and (d) show quantitative RNA expression of the MSC stemness
markers CD73 and CD105 in Kindlin-2 overexpressing and knockdown cells and their controls, respectively. Numbers in (b) indicate % cells
in quadrant gate. ∗Significance difference 𝑝 ≤ 0.05.
interacting with integrin𝛽 chains [20], but also contributes to
outside-in signaling by binding to integrin-linked kinase [21].
More recently, it has been shown that Kindlin-2 can regulate
integrin 𝛽1 protein expression in adult cardiomyocytes [22].
Kindlin-2 is also involved in regulating cancer cell invasions
with varying functions in different cancer types [23].
Generally, affinity regulation but not regulation of
integrin expression levels influences integrin activation.
Although a variety of targets of Kindlin-2 such as the
MIR-200 family and migfilin have been already described
[24, 25] as mediators for enhanced adhesion, migration,
and invasion, these effects remained controversial because
Kindlin-2 overexpression/knockdown is not always the same
in different cell types. For instance, Kindlin-2 overexpression
promotes prostate cancer stem cell proliferation [26], whereas
it reduces both cell division in colorectal cancer cells [6] and
mesenchymal cancer invasion [27]. The use of a Kindlin-2
mutant with a defect in binding to integrin could further
clarify the involvement of integrin binding in the observed
functions of Kindlin-2 in our study.
We hypothesized that if Kindlin-2 increased prolifera-
tion, adhesion, and migration in iPS-MSCs, studying this
protein might provide highly proliferative MSCs that can
retain or outperform the therapeutically desired functional
characteristics of normal MSCs and might address their
deficiencies [28, 29]. Our data indicated that Kindlin-2
was expressed in BM-MSCs at significantly higher levels
than the iPSCs that we used to differentiate iPSC-MSCs
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Figure 4: Continued.
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Figure 4: Differentiation capacity of iPSC-MSCs after Kindlin-2 transfection. Osteogenic, chondrogenic, and adipogenic differentiation
potential of hiPSC-MSCs after transfection with constructs modulating Kindlin-2. Alizarin Red staining for mineralized deposits (a), Alcian
Blue staining for chondrocyte pellets (b), and Oil Red-O staining for lipid formation (c) formed by the three iPSC-MSC cell lines.ThemRNA
expression level of the relative expression of genes associated with osteogenesis (osteocalcin and alkaline phosphatase), chondrogenesis
(collagen type II and aggrecan), and adipogenesis (PPAR-𝛾 and LPL). The data represent the mean expression values normalized to the
housekeeping gene GAPDH. Magnification is 10x. ∗Significance difference 𝑝 ≤ 0.05.
(Figure 1(a)). During embryonic development, Kindlin-2,
which is weakly expressed in embryonic stem cells, begins
to accumulate at increased levels in mesodermal-derived
tissues [3, 30, 31]. Furthermore, the expression of Kindlin-
2 increases as epithelial-shape embryonic stem cells proceed
through epithelial-mesenchymal transition (EMT) towards
mesodermal-differentiated cells [32]. As shown in Figure 1(a),
newly differentiated iPSC-MSCs expressed relatively low
amounts of Kindlin-2 mRNA and protein. However, this
expression increased in later passages.
4.2. Kindlin-2 Targets the CXCR-4/SDF-1𝛼 Axis. We also
showed that alteration of Kindlin-2 expression in iPS-MSCs
(Figure 1(b)) positively influenced expression of the newly
identified Kindlin-2 target, CXCR-4. This indicates that
Kindlin-2 may increase cell adhesion and migration through
increasing expression of CXCR4 or its availability at the
cell surface [33]. Engineered MSCs with high expression of
CXCR-4 were shown to have an enhancedmigration capacity
and also homing ability in irradiated mice, which is related
to SDF-1𝛼 levels inside the bone marrow [34]. Moreover,
the CXCR-4/SDF-1𝛼 axis had a major influence on MSCs
recruitment to tissues, chemotaxis, and homing [35].
Increased levels of CXCR-4 in iPSC-MSCs due to
Kindlin-2 overexpression may be the key factor in the
boosted adhesive capability of the cells to VCAM-1/SDF-1𝛼
coated flow chamber slides under high levels of shear stress
and also better migratory potential. We performed an adhe-
sion assay with VCAM-1 and fibronectin, which were not
affected by Kindlin-2 overexpression/knockdown (Supple-
mentary Figure 1 in Supplementary Material available online
at https://doi.org/10.1155/2017/7316354). Our findings sup-
port previous studies that indicated that enhanced CXCR-4
expression could lead to improved migration potential and
MSCs adhesion in the affected sites [36–38].
4.3. Kindlin-2 Overexpression Upregulates Proliferation in
iPSC-MSCs. Yet, there is still controversy about the influence
of Kindlin-2 on cell proliferation. Previously, Kindlin-2 was
known as a mitogen-activating protein that led to enhanced
proliferation [for a review, see [39]]. However, recently, it has
been demonstrated that Kindlin-2 overexpression does not
10 Stem Cells International
0 0.35 2 5 8 15
Flag control
Kindlin-2 Flag
shRNA control
Kindlin-2 shRNA
Shear stress (dyn/cm2)
∗
∗
∗
∗
0
20
40
60
80
100
Figure 5: Kindlin-2 boosts iPSC-MSCs adhesion to slides coated with VCAM-1 + SDF1𝛼. The iPSC-MSCs transfected with Kindlin-2 Flag
and shRNA adhered to the flow chamber slide coated with VCAM-1/SDF-1𝛼 under shear stress. Kindlin-2 Flag transfected iPSC-MSCs had
significantly higher attachment to the slides cocoated with VCAM-1 + SDF-1𝛼 under shear flow velocities of 0, 2, and 5 dynes/cm2 with
10x magnification compared to control Flag. The values shown are mean ± SEM of three independent experiments. ∗Significance difference
against Flag control 𝑝 ≤ 0.05.
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Figure 6: Kindlin-2 affects migration potential of iPSC-MSCs. An in vitro migration assay was performed with an IBIDI culture insert
containing two reservoirs separated by a 500𝜇m thick wall. Kindlin-2 Flag transfected iPS-MSCs had significantly increased migration
potential after 24 h and 36 h compared to control groups (a). Moreover, the migration assay with a transwell system showed significantly
increased migrating iPSC-MSCs on the lower face of the filters after 48 h of incubation in Kindlin-2 Flag transfected iPSC-MSCs compared
to control Flag (b). The covered area between the two reservoirs was analyzed with ImageJ software. ∗Significance difference 𝑝 ≤ 0.05. 𝑛 = 3.
always amplify proliferation but decreases cell division [6,
27]. To this end, we showed here that Kindlin-2 overexpres-
sion led to higher proliferation in iPSC-MSCs, whereas its
knockdown increased apoptosis. Regarding MSCs infusion
therapies, MSCs with enhanced proliferation, migration, and
homing ability (adhesion) are favorable and have long-term
beneficial effects on the healing of injured areas [40]. So far,
our Kindlin-2 Flag transfected iPSC-MSCs are approaching
the characteristics of “superfunctional” MSCs as a suitable
substitute for normal MSCs in cell infusion therapies. How-
ever, it is still necessary to transplant them and investigate
their tumorigenic potential.
4.4. Kindlin-2 Overexpression Downregulates Multilineage
Differentiation of iPSC-MSCs. We have described the intact
differentiation potential and the immune suppressive abil-
ities of iPSC-MSCs in a previous study [10]. Here, we
found that Kindlin-2 knockdown rendered iPSC-MSCsmore
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Figure 7: iPSC-MSCs suppress inflammatory reaction after transfection with Kindlin-2. To investigate the immunomodulatory properties
of iPSC-MSCs after Kindlin-2 overexpression/knockdown, mixed lymphocyte reaction (MLR) was used to mimic an inflammatory reaction
by mixing CD4+ lymphocytes with healthy donor peripheral blood mononuclear cells (PMNCs) on iPSC-MSCs or BM-MSCs feeder layers.
(a) CD4+ lymphocyte proliferation in an MLR assay using BrdU incorporation. The iPSC-MSCs/BM-MSCs could significantly (𝑝 ≤ 0.05)
decrease lymphocyte proliferation in all four groups compared to MLR without a feeder layer. No significant differences were found between
the different MSC groups (not indicated). (b and c) Production of cytokines IFN-𝛾 and IL-2 in the supernatant of MLR assays from the iPSC-
MSC/BM-MSCs coculture experiments. A significant decrease of IFN-𝛾 levels was observed between controls without MSCs and iPSC-MSC
or BM-MSCs coculture experiments in all four groups, but no significant differences were noted betweenMSC groups (b). Compared toMLC
without MSCs, IL-2 significantly decreased only in the Kindlin-2 overexpression group and not in other groups compared to MLR without a
feeder (c). ∗Significance difference 𝑝 ≤ 0.05.
prone to differentiation into three mesodermal lineages,
whereas Kindlin-2 overexpression dampened these pro-
cesses. Recently, Wu et al. showed that Kindlin-2 knock-
down in differentiated cells, such as chondrocytes, reduced
their density by inhibiting TGF-𝛽1-induced Smad-2 phos-
phorylation, which led to lower cell doubling rates and
increased apoptosis.Those results are in linewith our findings
[41]. However, Kindlin-2 knockdown mice in this previous
study lacked primary ossification centers and differenti-
ated chondrocytes due to increased apoptosis in primary
mesenchymal progenitors in vivo [41]. Our data indicates
that, after Kindlin-2 Flag transfection, the differentiation
affinity of iPSC-MSCs is significantly diminished using both
morphology and differentiation markers, whereas Kindlin-2
knockdown increased the differentiation potential of iPSC-
MSCs in vitro.
4.5. Kindlin-2 Overexpression Did Not Change Immunomodu-
latory Effects of iPSC-MSCs. The immune suppressive capac-
ity of iPSC-MSCs and BM-MSCs remained intact after
Kindlin-2 overexpression/knockdown in our study.The capa-
bility to induce immune tolerance of pluripotent stem cell-
derived MSCs and BM-MSCs is one of the fundamental
criteria that makes them a promising source for cell trans-
plantation therapies in graft versus host disease (GVHD) [42,
43]. Recently, Cheng et al. have shown reduced proliferation
of CD4+ and CD8+ T-cell populations along with a reduction
in the proinflammatory cytokines IFN-𝛾 and IL-2 and an
increased number of regulatory T-cells after transplantation
of pancreatic islets with iPSC-MSCs [44]. We previously
showed that iPSC-MSCs could suppress immune reactions
the same as BM-MSCs [10]. In the current study, after
Kindlin-2 overexpression and knockdown, iPSC-MSCs could
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still significantly reduce the number of CD4+ T-cells (Fig-
ure 7(a)) and proinflammatory cytokines (IL-2 and IFN-𝛾)
secretion (Figures 7(b) and 7(c)).This indicates that Kindlin-
2 overexpression and knockdown did not eliminate the
beneficial role of iPSC-MSCs and BM-MSCs in suppressing
the immune reaction.
5. Conclusion
Based on our hypothesis, we found that Kindlin-2 overex-
pression increased the proliferative potential of iPSC-MSCs
with less apoptosis and enhanced their migration potential
and adhesion to VCAM-1/SDF-1𝛼 under shear stress by
increasing the expression of CXCR-4. We also showed that
Kindlin-2 overexpression decreased the ability of iPSC-MSCs
to differentiate into the adipogenic, osteogenic, or chondro-
genic lineages, while maintaining stemness markers. Our
findings indicated that the functional ability of iPSC-MSCs
to reduce the proliferation of CD-4+ T-cells and decrease
proinflammatory cytokines (IFN-𝛾 and IL-2) in an MLR
assay is still intact and generally not affected by Kindlin-
2 modification. Together, our data suggest that targeting
Kindlin-2 in iPSC-MSCs opens a new way towards cell-
therapeutic approaches employing functionally enhanced
MSCs.
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